Suppr超能文献

从小鼠肿瘤中获得的无细胞腹水的抑制活性。可溶性Fc受体作为一种可能的活性剂。

Suppressive activity of cell-free ascites obtained from murine tumors. Soluble Fc receptor as a possible active agent.

作者信息

Gabrilovac J, Pachmann K, Thierfelder S

出版信息

Res Exp Med (Berl). 1981;178(2):131-40. doi: 10.1007/BF01851487.

Abstract

It has been shown that cell-free ascites (CFA) from Ehrlich carcinoma, AKR leukemia, and CBA thymoma, which all had strong suppressive activity in vivo, inhibit EA-rosette formation, complement-dependent hemolysis, and agglutinate EA-complexes. Since these are the characteristics of soluble FcR the data suggest the presence of FcR in CFA tested. To test whether the suppressive activity observed in vivo was due to the soluble FcR and FcR-like fraction was absorbed out from CFA or Ehrlich carcinoma by means of antigen-antibody complexes. The isolated FcR-like fraction was strongly suppressive in vivo. Additional support for the proposition that soluble FcR might be one of the mediators of suppression in vivo was gained by testing cell-free supernatants (CFS) of cell-line cells known to shed off FcR into the medium. It could be shown that CFS of highly FcR positive K-562 cells inhibited PFC stronger than did the CFS of weakly FcR positive Raji cells.

摘要

业已表明,来自艾氏癌、AKR白血病和CBA胸腺瘤的无细胞腹水(CFA)在体内均具有很强的抑制活性,可抑制EA玫瑰花结形成、补体依赖性溶血并凝集EA复合物。由于这些是可溶性FcR的特征,数据表明所测试的CFA中存在FcR。为了测试在体内观察到的抑制活性是否归因于可溶性FcR,通过抗原-抗体复合物从CFA或艾氏癌中吸收FcR样部分。分离出的FcR样部分在体内具有很强的抑制作用。通过测试已知会将FcR释放到培养基中的细胞系细胞的无细胞上清液(CFS),进一步支持了可溶性FcR可能是体内抑制介质之一的观点。结果表明,高FcR阳性的K-562细胞的CFS比低FcR阳性的Raji细胞的CFS对PFC的抑制作用更强。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验